Pharma's Almanac TV
PA TV
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2021 Cell & Gene Therapy Report
2021 Monoclonal Antibody & Recombinant Protein Market Report
2021 Sterile Drug Market Report
2021 API Market Report
2020 OSD Market Report
Community
Company A to Z
More+
Staffing
Media Kit
CDMO
520 Articles Available
1
22
Can't find what you're looking for? Try our
advanced search
.
Biotech-CDMO Relationship
Illustrating a Successful Small Biotech-CDMO Relationship
PAO-08-21-CL-03
Gene Therapy
Andelyn Biosciences: A New CDMO with Roots in Gene Therapy Research Set to Drive Key Manufacturing Advances
Quality
The Future of the Delivery of Quality
PAO-07-21-CL-01
Client Service
Avara on Client Service and Innovation— We Make It. About You.
PAO-07-21-CL-07
Quality
Strong Quality Systems and Quality Culture Ensure Inspection-Ready Status
PAO-06-21-CL-12
Facility Acquisition
TriRx Enters Agreement for the Acquisition of Elanco Animal Health Facilities in Shawnee, Kansas and Speke, United Kingdom
PR-M06-21-019
Live Biotherapeutic Products
Framing the Narrative on CMC Development for Microbiome Therapeutics
PAO-06-21-CL-05
Collaboration
Collaboration in Action: New Milestones Efficiency and Simplifying the Complexities of Drug Development
PAO-06-21-CL-02
Cell and Gene Therapy
Expanding a Comprehensive Platform to Support the Future of Cell and Gene Therapies
PAO-05-21-CL-05
Quality
Quality and Compliance Ensures Business Sustainability for Avara Arecibo Clients
PAO-05-21-CL-04
COVID-19 Vaccines
The COVID-19 Vaccine Journey Continues
PAO-05-21-NI-02
Strategic Growth
Unique Commercial Experience Primes Avid Bioservices for Growth
PAO-05-21-CL-03
Capacity Expansion
German CDMO Richter-Helm Triples cGMP Production Capacity to Accommodate Global Market Demand
PR-M05-21-008
Cell and Gene Therapy
CAR-T Cell and Gene Therapy Market: Challenges and Opportunities
Partnership
BioVectra and PhaseBio Discuss Creating an Optimal Partnership
PTV-04-21-CL-001
Lyophilization
Shorten Time to Market with New Data-Driven Lyophilization Process
PAO-03-21-CL-07
Biosimilars
Successful Biosimilar Development Requires an Outsourcing Partner with the Right Experience
PAO-03-21-CL-03
Supply Agreement
PhaseBio Pharmaceuticals and BioVectra Enter into Supply Agreement to Support Development and Commercialization of Bentracimab
PR-M11-20-048
HPAPI
A Successful Approach for Managing Unexpected Increases in Potency for HPAPIs
PAO-01-21-CL-01
Single-Use Technology
Stainless Steel to Single-Use: How to Adapt to the Changing Landscape in SUT
PAP-Q4-20-CL-004
Industry Leader
Shaping the Future of Biopharma Through Next-Generation Contract Drug Manufacturing
PAP-Q4-20-CL-023
Small Molecule
The Importance of a Global Leader in Small Molecule Manufacturing During the COVID-19 Pandemic
PAP-Q4-20-CL-025
Antibody–Drug Conjugates
Preparing for the ADC Explosion with End-to-End Support
PAP-Q4-20-CL-014
Specialized OSD Services
Avara Pharmaceutical Services: Specialization with a Client-Centric Approach
PAP-Q4-20-CL-003
1
22
»
